Firefly Neuroscience is collaborating with Prof. Dr. med. Christian Schaaf of Heidelberg University Hospital on a study investigating the...

Iovance Biotherapeutics announced positive real-world data for its commercially available melanoma treatment, Amtagvi (lifileucel). A study of 41 patients...

BriaCell Therapeutics Corp. announced positive Phase 2 survival data for its lead immunotherapy candidate, Bria-IMT, combined with an immune...

Capricor Therapeutics received a Complete Response Letter (CRL) from the FDA regarding its Biologics License Application (BLA) for Deramiocel,...

Italfarmaco presented new cardiac data for givinostat, its histone deacetylase (HDAC) inhibitor, at the 2025 European Paediatric Neurology Society...

Rhythm Pharmaceuticals presented data from its clinical programs for acquired hypothalamic obesity at the Endocrine Society’s Annual Meeting (ENDO...

KIF18A, a mitotic kinesin motor protein overexpressed in cancers like ovarian and triple-negative breast cancers, is emerging as a...

Crinetics Pharmaceuticals released new clinical data on its oral acromegaly drug, paltusotine (PALSONIFY), at ENDO 2025. The data, from...

Longeveron Inc. received FDA approval for its Investigational New Drug (IND) application for laromestrocel, a stem cell therapycell therapy...

Plus Therapeutics has begun treating the first patients in its ReSPECT-LM dose optimization trial for REYOBIQ™, a targeted radiotherapeutic...